Name

MDRV Gene

muscular dystrophy, with rimmed vacuoles

MLIP Gene

muscular LMNA-interacting protein

Predicted to enable lamin binding activity and transcription corepressor activity. Predicted to be involved in negative regulation of cardiac muscle hypertrophy in response to stress; negative regulation of transcription by RNA polymerase II; and positive regulation of transcription by RNA polymerase II. Predicted to be located in PML body; nuclear envelope; and sarcolemma. [provided by Alliance of Genome Resources, Mar 2025]

LGMD1H Gene

limb girdle muscular dystrophy 1H (autosomal dominant)

LGMD1G Gene

limb girdle muscular dystrophy 1G (autosomal dominant)

MDC1B Gene

Muscular dystrophy, congenital, 1B

FSHMD1A Gene

facioscapulohumeral muscular dystrophy 1A

Facioscapulohumeral muscular dystrophy (FSHD) is a common hereditary disease of muscle. Patients with FSHD have a chromosomal rearrangement within the subtelomeric region of chromosome 4 (4q35). This region is composed mainly of a polymorphic repeat structure consisting of 3.3 kb repeat units, designated D4Z4. The number of repeat units varies from 10 to more than 100 in the population, however, in FSHD patients only 1-10 repeat units is observed because of a deletion of an integral number of these units. FSHD is caused by an epigenetic mechanism involving the contraction of a subtelomeric macrosatellite repeat, which results in marked hypomethylation of the contracted D4Z4 allele. It is likely not the structure, but the deregulation of transcription of one or more genes as a result of repeat-contraction-mediated chromatin alterations, that causes FSHD. [provided by RefSeq, Sep 2011]

FSHMD1B Gene

facioscapulohumeral muscular dystrophy 1B

SMAR Gene

Spinal muscular atrophy, chronic distal, autosomal recessive

SMAL Gene

spinal muscular atrophy, congenital nonprogressive, of lower limbs

SCA18 Gene

spinocerebellar ataxia 18 (sensory with neurogenic muscular atrophy)

MDCMP Gene

muscular dystrophy, congenital, merosin-positive

SMAJ Gene

Spinal muscular atrophy, Jokela type

BFIS1 Gene

benign familial infantile convulsions

NYS5 Gene

Nystagmus 5, infantile periodic alternating

CLN6 Gene

ceroid-lipofuscinosis, neuronal 6, late infantile, variant

This gene is one of eight which have been associated with neuronal ceroid lipofuscinoses (NCL). Also referred to as Batten disease, NCL comprises a class of autosomal recessive, neurodegenerative disorders affecting children. The genes responsible likely encode proteins involved in the degradation of post-translationally modified proteins in lysosomes. The primary defect in NCL disorders is thought to be associated with lysosomal storage function. [provided by RefSeq, Oct 2008]

BFIS4 Gene

Convulsions, benign familial infantile, 4

PKDTS Gene

polycystic kidney disease, infantile severe, with tuberous sclerosis

BFIC2 Gene

Benign familial infantile convulsions-2

EIM Gene

Infantile myoclonic epilepsy

GLC3B Gene

glaucoma 3, primary infantile, B

IHPS2 Gene

Pyloric stenosis, infantile hypertrophic, 2

CMS1A1 Gene

myasthenia gravis, familial infantile, 1

IHPS5 Gene

Pyloric stenosis, infantile hypertrophic, 5

IHPS4 Gene

Pyloric stenosis, infantile hypertrophic, 4

IHPS3 Gene

Pyloric stenosis, infantile hypertrophic, 3